共 50 条
- [42] Ozanimod Demonstrates Efficacy and Safety in a Multicenter, Randomized, Double-Blind, Double-Dummy, Active-Controlled Phase 3 Trial of Relapsing Multiple Sclerosis (SUNBEAM)NEUROLOGY, 2018, 90Comi, GiancarloArnold, DouglasCree, BruceKappos, LudwigSelmaj, KrzysztofBar-Or, AmitSteinman, LawrenceHartung, Hans-PeterMontalban, XavierHavrdova, EvaSheffield, JamesRaghupathi, KartikCohen, Jeffrey
- [43] Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trialBRITISH JOURNAL OF PSYCHIATRY, 2023, 223 (06) : 533 - 541Loo, ColleenGlozier, NickBarton, DavidBaune, Bernhard T.Mills, Natalie T.Fitzgerald, PaulGlue, PaulSarma, ShanthiGalvez-Ortiz, VeronicaHadzi-Pavlovic, DusanAlonzo, AngeloDong, VanessaMartin, DonelNikolin, StevanMitchell, Philip B.Berk, MichaelCarter, GregoryHackett, MareeLeyden, JohnHood, SeanSomogyi, Andrew A.Lapidus, KyleStratton, ElizabethGainsford, KirstenGarg, DeepakThornton, Nicollette L. R.Fourrier, CeliaRichardson, KarynRozakis, DemiScaria, AnishMihalopoulos, CathrineChatterton, Mary LouMcDonald, William M.Boyce, PhilipHoltzheimer, Paul E.Kozel, F. AndrewRiva-Posse, PatricioRodgers, Anthony
- [44] BouNDless: An active-controlled randomized, double-blind double-dummy study of continuous ND0612 infusion in patients with fluctuating Parkinson's diseaseMOVEMENT DISORDERS, 2019, 34 : S74 - S74Poewe, W.Kieburtz, K.Stocchi, F.Oren, S.Yardeni, T.Adar, L.Rosenfeld, O.Olanow, C.
- [45] A double-blind, randomised, placebo-controlled trial to investigate the efficacy and safety of nebicapone in levodopa-treated Parkinson's disease patients with motor fluctuationsMOVEMENT DISORDERS, 2008, 23 (01) : S195 - S195Ferreira, J. J.Rascol, O.Poewe, W.Sampaio, C.Rocha, F.Nunes, T.Almeida, L.Soares-da-Silva, P.
- [46] Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trialLANCET NEUROLOGY, 2024, 23 (01): : 37 - 45Mcgarry, AndrewRosanbalm, ShaneLeinonen, MikaOlanow, WarrenTo, DennisBell, AdamLee, DanielChang, JamieDubow, JordanDhall, RohitBurdick, DanielParashos, SotiriosFeuerstein, JeanneQuinn, JosephPahwa, RajeshAfshari, MitraRamirez-Zamora, AldolfoChou, KelvinTarakad, ArjunLuca, CorneliuKlos, KevinBordelon, YvetteSt Hiliare, Marie-HeleneShprecher, DavidLee, SeulkiDawson, Ted M.Roschke, ViktorKieburtz, Karl
- [47] Efficacy and safety of filgotinib as induction and maintenance therapy for Crohn's disease (DIVERSITY): a phase 3, double-blind, randomised, placebo-controlled trialLANCET GASTROENTEROLOGY & HEPATOLOGY, 2025, 10 (02): : 138 - 153Vermeire, SeverineSchreiber, StefanRubin, David T.D'Haens, GeertReinisch, WalterWatanabe, MamoruMehta, RajivRoblin, XavierBeales, IanGietka, PiotrHibi, ToshifumiHospodarskyy, IhorRitter, TimothyGenovese, Mark C.Kwon, PaulSantermans, EvaLe Brun, Franck-OlivierBarron, RahulMasior, TomaszDanese, Silvio
- [48] The BouNDless Study: An Active-Controlled, Randomized, Double-Blind, Double-Dummy Phase 3 Study of Continuous ND0612 Infusion in Patients with Parkinson's Disease Experiencing Motor FluctuationsNEUROLOGY, 2020, 94 (15)Espay, AlbertoRascol, OlivierYardeni, TamarAdar, LiatRosenfeld, OliviaCase, RyanOlanow, C. Warren
- [49] Randomized, Double-Blind, Active-Controlled Phase 3 Study to Evaluate Efficacy and Safety of Zastaprazan Compared With Esomeprazole in Erosive EsophagitisAMERICAN JOURNAL OF GASTROENTEROLOGY, 2025, 120 (02): : 353 - 361Oh, Jung-HwanKim, Hyun-SooCheung, Dae YoungLee, Hang LakLee, Dong HoKim, Gwang HaChoi, Suck CheiCho, Yu KyungChung, Woo ChulKim, Ji WonYu, EunjuKwon, HyesooKim, JunKim, JohnJung, Hwoon-Yong
- [50] Presentation: Efficacy and Safety of Apomorphine Sublingual Film for the Treatment of "OFF" Episodes in Patients with Parkinson's Disease: A Phase 3, Double-Blind, Placebo-Controlled TrialMOVEMENT DISORDERS, 2019, 34 : S1 - S1Factor, S. A.Isaacson, S.Hauser, R. A.Pahwa, R.Sciarappa, K.Bhargava, P.Vakili, G.Blum, D.Navia, B.Olanow, C. W.